Well said @stockrock …. Some of the dreamers on here expect a...

Well said @stockrock …. Some of the dreamers on here expect a Mesoblast turnaround when Starpharma has very little left by the looks? Comparing the 2 companies is laughable.

E.g. Starpharma can’t even secure a DEP license deal and so have resorted to once again giving it away by the looks if the recent Medicxi deal is anything to go by and we are going back to the drawing board chasing radiotherapies.


All the new CEO has done is clear the decks while delivering nothing of substance to date; hence the 9 cent share price. Substantial Holders continue to dump at huge losses and the TGA are dragging their feet in relation to a Viraleze approval given it’s been circa 3 years in the making (not that this will do much for the share price) ….. a truly sad state of affairs after all that was touted by the previous CEO for years. A good write off against massive FMG gains though so there is that silver lining but apart from that most LT shareholders have headed for the exits right alongside of the Substantial Holders